NAGE Q3'26 Earnings: EPS estimate is 0.00 USD

What happened

Niagen Bioscience is scheduled to announce its Q3'26 results on November 4, after the market closes, with disclosure expected at 4:02 p.m. ET. The supplied estimate is revenue of $31.60 million and earnings per share (profit allocated to each share) of $0.00.

Confirmed

Global impact / market context

The results will show whether sales matched the $31.60 million estimate and whether earnings per share reached the expected break-even level. A shortfall could signal weaker revenue or higher costs, while stronger results could improve investors’ view of the company’s ability to generate profit.

Analyst inference

Niagen Bioscience is scheduled to report third-quarter 2026 results after the market closes on November 4. The estimate is revenue of 31.60 million USD and earnings per share of 0.00 USD. These are forecasts, not reported results; the release will show how actual performance compares.

Confirmed

What to watch

1. Check the reported revenue against the $31.60 million estimate; the difference will show whether sales were above or below the market’s stated expectation. Analyst inference
2. Compare reported earnings per share with the $0.00 estimate to see whether Niagen Bioscience reached break-even, meaning earnings were neither positive nor negative per share. Analyst inference
3. Look for company explanations of sales or costs alongside the results; these details could clarify what drove performance and whether the trends may persist. Analyst inference

Evidence

• Original source link unavailable